Finding Description
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations, review of the facility's infection control tracking logs, the infection control and prevention policy, and staff interviews it was determined the facility failed to develop and implement a comprehensive infection control program to prevent the spread of infectious diseases including scabies for two of 18 residents reviewed (Resident 56 and Resident CR1).
Findings include:
A review of the current facility policy for Infection Prevention and Control, last reviewed December 4, 2024, revealed it is the policy of the facility to maintain an organized, effective facility-wide program designed to systematically prevent, identify, control and reduce the risk of acquiring and transmitting infections among employees, volunteers, visitors and contract healthcare workers, to conduct surveillance of communicable disease and infectious outbreaks and to monitor employee health.
A review of a facility policy entitled Scabies Management reviewed December 4, 2024, revealed, the purpose of the policy is to treat residents infected with and sensitized to scabies and to prevent the spread of scabies to other residents and staff.
Affected residents should remain in contact precautions until 24 hours after treatment. Exposed staff members should report any rashes developing on their bodies to the Infection Preventionist or DON (Director of Nursing). A resident sharing a room with someone infected with scabies will be monitored for scabies. If symptoms are not present, daily assessments will occur until the case is resolved.
Clinical record review revealed that Resident 56 was admitted to the facility on [DATE], with diagnoses to include heart failure, hypertension (high blood pressure), and anxiety.
A quarterly MDS assessment (Minimum Data Set - a federally mandated standardized assessment conducted at specific intervals to plan resident care) dated September 2, 2024, revealed the resident to be moderately cognitively impaired with a BIMS (Brief Interview for Mental Status, a short cognitive screening tool used to assess a person's cognitive functioning) score of 12 (a score of 8 to 12 suggests moderate cognitive impairment) and required staff assistance for activities of daily living.
A review of a care plan initiated October 29, 2024 for skin integrity revealed the resident had a rash related to scabies with interventions to include, conduct a systematic skin inspection per facility policy, dermatology consult as needed, discourage resident from scratching area to reduce tissue damage, encourage resident to request medication before symptoms become unbearable, record the location, size (length, width, and depth), color, distribution, contour, consistency of rash(s) per facility policy, and monitor, document, and report to the provider any changes in color, temperature, sensation, pain or presence of drainage and/ or odor.
A review of nursing notes dated September 19, 2024, at 7:50 P.M. revealed the resident's daughter reported Resident 56 had a small rash on her upper right arm, and a small red area was noted. The Resident was noted to be scratching at the area. The rash was cleansed with soap and water. A note was left for the physician to examine the resident.
There was no documented nursing skin assessment completed at that time.
A review of nursing progress note dated September 20, 2024, at 4:56 P.M. revealed the nurse practitioner was in to see the resident and address the family concerns of the itchy rash. A new order was noted for Hydrocortisone cream 1% (steroid cream) to the rash twice a day until resolved and then reassess.
A review of a nursing progress note dated September 27, 2024, at 12:51 P.M. revealed the physician was in to see and examine the resident. The resident complained to the physician about an itchy rash to her right arm. New orders were noted to start a Medrol dose pack (oral steroids) and Clobetasol 0.05% cream (a medication used to treat skin conditions) twice a day for 5 days.
A review of a skin assessment dated [DATE] revealed, an existing skin issue noted, scab on lower mid back, with no redness. There was no documentation of a rash on the assessment form at that time.
A review of a nursing progress note dated October 6, 2024, at 8:51 A.M. revealed the physician was in to see the resident and a new order was noted to start Claritin (oral allergy medication)10 mg by mouth, daily for itch and Betamethasone (topical steroid cream)0.05 topical ointment apply topically to affected areas twice daily.
A review of a skin assessment dated [DATE], revealed, an existing skin issue noted. Scratches on lower mid back/ sacrum with no redness or drainage. There was no documentation of a rash on the assessment form at that time.
A review of a nursing progress note dated October 16, 2024, at 2:17 P.M. indicated the nurse practitioner saw the resident and discontinued the Claritin and wrote a new order to start Allegra (an oral allergy medication) 180 mg PO (by mouth) daily.
A review of a skin assessment dated [DATE] revealed, an existing skin issue noted, dermatitis throughout the resident's body with mid back and sacrum scratches.
A review of a skin assessment dated [DATE] revealed, an existing skin issue noted, scratches on the lower mid back and sacrum. No redness or drainage. Small red itchy bumps noted over te resident's entire body.
A review of a psychiatry note dated October 28, 2024, 8:24 A.M. by the contracted nurse practitioner stated the resident was seen for a follow up psychiatry visit. The resident stated that her mood is frustrated. The resident spoke in depth regarding her rash and management by her attending physician and lack of sleep. The resident reported anxiety related to her current situation.
A nursing note dated October 28, 2024, at 11:48 A.M. revealed, a call was placed to dermatology and an appointment was scheduled for October 29, 2024 at 9:00 A.M.
A nursing note dated October 29, 2024, at 10:34 A.M. revealed the resident returned from the dermatology appointment with diagnosis of scabies. A new order was noted to discontinue the Betamethasone (steroid cream) cream and to start Permethrin (anti-scabies treatment) cream apply topically from head to toe when sent from pharmacy, wash off in shower 12 hours post application, maintain contact precautions. Further recommendations included, clothing and bedding should be washed in hot water and any roommate should be treated for possible scabies.
Clinical record review revealed that Resident CR1 was admitted to the facility on [DATE], with diagnosis to include after care for a fracture (broken bone) and non-Hodgkin lymphoma (cancer). Resident CR1 and Resident 56 were roommates since Resident CR1's admission to the facility.
There was no evidence that after the October 29, 2024, dermatology consultation that Resident CR1 or her responsible party were notified of the diagnosis of scabies and offered treatment as recommended by the dermatology office.
A review of nursing documentation dated November 4, 2024 at 11:28 A.M. revealed nursing assessed the resident's skin fully. The resident had small areas where a rash remained. Multiple self-inflicted scratch marks were noted to bottom and top of the arms where there was no rash. The resident still complained of itching.
A nurses note dated November 4, 2024 at 4:03 P.M. revealed the physician was called regarding the resident's itching and a new order was noted for Benadryl (an allergy medication) 25mg by mouth every 6 hours as needed for 1 week.
A nurses note dated November 4, 2024, at 9:28 P.M. revealed the resident was upset rolling up and down halls and day room cursing at staff about medicines, other residents, her medical records, and food. The resident was unwilling/unable to articulate what was bothering her. Staff asked the resident to please refrain from bad language in public areas. The resident was offered Benadryl for itching, snacks, and drinks. Further the resident indicated she wants a lawyer to make her itching stop.
A review of a skin assessment dated [DATE], revealed, an existing skin issue noted, scratches on lower mid back, pimple-like area to right scapula, a rash to right mid back and flank area, and a rash to the right breast and under the right breast. There were no measurements for the noted areas or any additional description of the areas.
A nurses note dated November 5, 2024, at 1:28 P.M. indicated dermatology was called regarding the resident's continued complaints of itching, informed of new areas of concern. A new order was noted to start Betamethasone (steroid cream) ointment twice a day.
A nursing progress note dated November 5, 2024, at 10:35 P.M. revealed the second dose of permethrin cream was applied and was scheduled to be washed off in the morning.
A nurses note dated November 12, 2024, at 1:43 P.M. revealed, the resident was assessed with nursing and physician assistant. A new order noted for Caladryl (anti itch lotion) three times a day and make a follow up appointment with dermatology.
A nurses note dated November 13, 2024, at 2:26 P.M. revealed the resident returned from the dermatology appointment with new orders for Ivermectin (an oral anti scabies medication) 3 mg, take 4 tablets by mouth on day 1 and repeat 14 days later.
A review of a dermatology consultation report dated November 13, 2024, revealed the resident was seen for a follow up visit for scabies. The areas affected were noted as the arms, abdomen, back, buttocks, breast, chest, and legs. The areas were noted as worsened. The physician's findings included small papules and burrows with scales, excoriations, and crust located on the arms, breasts, abdomen, back and buttocks. Another two applications of the Permethrin cream was ordered at that time.
There was no evidence at the time of the survey that comprehensive and accurate skin assessments were completed for Resident 56 with symptoms displayed since September 19, 2024 to the survey ending December 12, 2024.
An interview with the ADON on November 11, 2024, at approximately 1:00 PM verified the facility failed to implement proper infection control practices, including the facility's established policy and procedures for skin assessments to prevent and mitigate further spread of scabies.
28 Pa Code 211.12 (d)(1)(2)(3)(5) Nursing Services
28 Pa. Code 201.18 (b)(1)(e)(1) Management